Zhao Wei-Xing, Zhang Jun-Han, Cao Jiang-Bei, Wang Wei, Wang Dong-Xin, Zhang Xiao-Ying, Yu Jun, Zhang Yong-Yi, Zhang You-Zhi, Mi Wei-Dong
Anesthesia and Operation Center, Chinese PLA General Hospital, 28th Fuxing Road, Haidian District, Beijing, 100853, China.
The Second Affiliated Hospital of Xiangya School of Medicine, Central South University, Changsha, 410008, China.
J Neuroinflammation. 2017 Jan 21;14(1):17. doi: 10.1186/s12974-016-0781-6.
Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice.
A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP.
Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice.
Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway.
大量证据表明,神经炎症和氧化应激在术后认知功能障碍(POCD)及其他进行性神经退行性疾病的病理生理学中起重要作用。越来越多的证据表明,对乙酰氨基酚(APAP)具有未被充分认识的抗氧化和抗炎特性。然而,APAP对炎症和氧化应激所致认知后遗症的影响尚不清楚。本研究的目的是探讨APAP是否对脂多糖(LPS)诱导的小鼠认知障碍具有神经保护作用。
建立LPS诱导的小鼠认知障碍模型,以评估APAP对LPS诱导的认知障碍的神经保护作用。成年C57BL/6小鼠在脑室内微量注射LPS前半小时及此后每天接受APAP治疗,直至研究期结束。在注射后第1至3天使用Morris水迷宫评估认知功能。进行动物行为测试以及病理和生化分析,以评估LPS诱导的海马损伤及APAP的神经保护作用。
用LPS处理的小鼠在Morris水迷宫中的表现受损,但自发运动活动未改变,而APAP治疗可改善这种情况。APAP抑制了LPS诱导的海马中促炎细胞因子的积累和小胶质细胞的激活。此外,APAP增加了超氧化物歧化酶(SOD)活性,降低了丙二醛(MDA)水平,调节了糖原合酶激酶3β(GSK3β)活性,并提高了海马中脑源性神经营养因子(BDNF)的表达。此外,APAP显著降低了LPS处理小鼠海马中的Bax/Bcl-2比值和神经元凋亡。
我们的结果表明,APAP可能通过其抗氧化和抗炎特性以及抑制线粒体通透性转换(MPT)孔及随后的凋亡途径,对LPS诱导的认知障碍以及炎症和氧化应激具有神经保护作用。